Nassir Habboubi

Nassir Habboubi has a strong background in research and development within the pharmaceutical industry. Nassir is currently serving as the Global Head of Research and Development at Menarini stemline since December 2021. Prior to this, they held the role of Chief Medical Officer/Global Head of R&D at Stemline Therapeutics, Inc. starting in January 2021.

From 2018 to 2021, Nassir Habboubi worked as the CMO at Celularity. Before that, they gained extensive experience at Novartis, where they served as the Vice President of US Clinical Development and Medical Affairs from 2009 to 2018.

Nassir Habboubi began their career at sanofi-aventis in 1999, where they held the position of Vice President Clinical Research Oncology in Malvern, PA until 2009. Overall, they have a strong track record in leadership roles within the pharmaceutical industry.

Nassir Habboubi completed their MD degree in Medical Doctor from the American University of Beirut, studying from 1979 to 1981. Following this, they pursued a fellowship in Oncology and Hematology from 1981 to 1984 at A.U.H. and M.D. Anderson Cancer Center Hospital.